LeMaitre Vascular Inc. (LMAT) Reaches New 1-Year High at $18.85
Shares of LeMaitre Vascular Inc. (NASDAQ:LMAT) hit a new 52-week high during mid-day trading on Tuesday . The company traded as high as $18.85 and last traded at $18.64, with a volume of 113,039 shares. The stock had previously closed at $18.04.
A number of analysts recently issued reports on the stock. Zacks Investment Research raised shares of LeMaitre Vascular from a “hold” rating to a “buy” rating and set a $18.00 price target on the stock in a report on Thursday, May 5th. Barrington Research increased their price target on shares of LeMaitre Vascular from $18.50 to $20.00 and gave the stock an “outperform” rating in a report on Thursday, July 28th. Canaccord Genuity set a $19.00 price target on shares of LeMaitre Vascular and gave the stock a “buy” rating in a report on Thursday, July 28th. Finally, Brean Capital increased their price target on shares of LeMaitre Vascular from $17.50 to $20.00 and gave the stock a “buy” rating in a report on Thursday, July 28th. Seven equities research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the stock. The stock has a consensus rating of “Buy” and an average target price of $18.72.
The company has a market cap of $339.37 million and a price-to-earnings ratio of 36.91. The stock’s 50-day moving average is $16.47 and its 200-day moving average is $15.24.
LeMaitre Vascular (NASDAQ:LMAT) last announced its earnings results on Wednesday, July 27th. The company reported $0.14 EPS for the quarter, beating analysts’ consensus estimates of $0.11 by $0.03. The business earned $22.40 million during the quarter, compared to analyst estimates of $21.59 million. The firm’s revenue for the quarter was up 12.6% on a year-over-year basis. On average, analysts predict that LeMaitre Vascular Inc. will post $0.55 EPS for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 6th. Stockholders of record on Monday, August 22nd will be issued a $0.045 dividend. The ex-dividend date of this dividend is Thursday, August 18th. This represents a $0.18 dividend on an annualized basis and a dividend yield of 0.98%.
In other news, insider Peter R. Gebauer sold 26,815 shares of LeMaitre Vascular stock in a transaction on Monday, August 29th. The shares were sold at an average price of $17.78, for a total value of $476,770.70. Following the transaction, the insider now directly owns 31,283 shares of the company’s stock, valued at approximately $556,211.74. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Peter R. Gebauer sold 6,310 shares of LeMaitre Vascular stock in a transaction on Monday, June 6th. The shares were sold at an average price of $14.96, for a total transaction of $94,397.60. Following the completion of the transaction, the insider now directly owns 53,339 shares in the company, valued at $797,951.44. The disclosure for this sale can be found here.
LeMaitre Vascular, Inc is a provider of medical devices for the treatment of peripheral vascular disease. The Company and its subsidiaries develop, manufacture and market medical devices and implants used primarily in the field of vascular surgery. It operates in the design, marketing, sales and technical support of medical devices and implants for the treatment of peripheral vascular disease industry segment.